Huadong Medicine

Last updated
Huadong Medicine Pvt Ltd
SZSE: 000963
Industry Pharmaceuticals
Founded1993
Headquarters Hangzhou, China
Website www.eastchinapharm.com

HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China. [1]

Related Research Articles

<span class="mw-page-title-main">Renminbi</span> Official currency of the Peoples Republic of China

The renminbi is the official currency of the People's Republic of China. It is the 5th most traded currency as of April 2022.

<span class="mw-page-title-main">GSK plc</span> British multinational pharmaceutical and biotechnology company

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK is the tenth largest pharmaceutical company and #294 on the 2022 Fortune Global 500, ranked behind other pharmaceutical companies China Resources, Sinopharm, Johnson & Johnson, Pfizer, Roche, AbbVie, Novartis, Bayer, and Merck.

<span class="mw-page-title-main">Henan University of Chinese Medicine</span>

Henan University of Chinese Medicine Chinese: 河南中医药大学 Hénán Zhōngyīyào dàxué) is a public university in Zhengzhou, Henan, China.

<span class="mw-page-title-main">Shenyang Pharmaceutical University</span>

Shenyang Pharmaceutical University is a university in Shenyang, Liaoning, China. It is the first research institute in pharmaceutical sciences in China.

The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 50% of all vaccines manufactured in the world. With industry standards compliant mega production capabilities and large number of skilled domestic workforce, Indian exports meet the standards and requirements of highly regulated markets of USA, UK, European Union and Canada. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19.

<span class="mw-page-title-main">Yuzhou, Henan</span> County-level city in Henan, Peoples Republic of China

Yuzhou is a county-level city in the central part of Henan, People's Republic of China. It occupies the northwest corner of the prefecture-level city of Xuchang. The city is named for Yu the Great, the founder of the Xia Dynasty, which the city's government claims was founded in present-day Yuzhou, and that the dynasty's capital was located in present-day Yuzhou. There is a statue of Yu the Great in Yuzhou, and he serves as a symbol of the city.

<span class="mw-page-title-main">Andrew Witty</span> British business executive (born 1964)

Sir Andrew Philip Witty is a British business executive, who is the current chief executive officer (CEO) of UnitedHealth Group. He was also the CEO of GlaxoSmithKline between 2008 and 2017. He formerly held the role of chancellor of the University of Nottingham.

Pharmacy in China involves the activities engaged in the preparation, standardization and dispensing of drugs, and its scope includes the cultivation of plants that are used as drugs, the synthesis of chemical compounds of medicinal value, and the analysis of medicinal agents. Pharmacists in China are responsible for the preparation of the dosage forms of drugs, such as tablets, capsules, and sterile solutions for injection. They compound physicians', dentists', and veterinarians' prescriptions for drugs. Pharmacological activities are also closely related to pharmacy in China.

<span class="mw-page-title-main">China Nepstar</span>

China Nepstar Chain Drugstore Ltd., which conducts business as China Nepstar, is China's largest retail drugstore chain, based on the number of directly operated stores. It is headquartered in Nanshan District, Shenzhen.

Fetion was an instant messaging (IM) client developed by China Mobile, a Chinese telecommunications company. It allows users to send and receive SMS free of charge between PCs and mobile phones. China Mobile intends to develop Fetion into a comprehensive communications service which will focus on wireless communications and offer the Internet applications as a complement. D-media Communication Tech undertakes construction, operation and maintain of Fetion.

<span class="mw-page-title-main">Ganquan County</span> County in Shaanxi, Peoples Republic of China

Ganquan County is a county in the north of Shaanxi province, China. It is under the administration of the prefecture-level city of Yan'an. The county has an area of 2,276.1 square kilometres (878.8 sq mi), and a population of 77,800 as of 2012.

<span class="mw-page-title-main">Sinopharm (company)</span> Chinese state-owned enterprise

China National Pharmaceutical Group Corporation (CNPGC), commonly referred to as Sinopharm, is a Chinese state-owned enterprise. The corporation was the indirect major shareholder of publicly traded companies Sinopharm Group, China Traditional Chinese Medicine, Shanghai Shyndec Pharmaceutical, and Beijing Tiantan Biological Products.

The pharmaceutical industry in the United Kingdom directly employs around 73,000 people and in 2007 contributed £8.4 billion to the UK's GDP and invested a total of £3.9 billion in research and development. In 2007 exports of pharmaceutical products from the UK totalled £14.6 billion, creating a trade surplus in pharmaceutical products of £4.3 billion.

Since the late-2000s, the People's Republic of China (PRC) has sought to internationalize its official currency, the Renminbi (RMB). RMB internationalization accelerated in 2009 when China established the dim sum bond market and expanded Cross-Border Trade RMB Settlement Pilot Project, which helps establish pools of offshore RMB liquidity. The RMB was the 8th-most-traded currency in the world in 2013 and the 7th-most-traded in early 2014. By the end of 2014, RMB ranked 5th as the most traded currency, according to SWIFT's report, at 2.2% of SWIFT payment behind JPY (2.7%), GBP (7.9%), EUR (28.3%) and USD (44.6%). In February 2015, RMB became the second most used currency for trade and services, and reached the ninth position in forex trading. The RMB Qualified Foreign Institutional Investor (RQFII) quotas were also extended to five other countries — the UK, Singapore, France, Korea, Germany, and Canada, each with the quotas of ¥80 billion except Canada and Singapore (¥50bn). Previously, only Hong Kong was allowed, with a ¥270 billion quota.

Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.

The distribution of medications has special drug safety and security considerations. Some drugs require cold chain management in their distribution.

Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular medication, painkillers, antibiotics, and related products. It is the largest listed pharmaceutical company in China.

References

  1. China Listed Companies Handbook (Vol 4). Javvin Technologies. 2008. p. 69. ISBN   978-1-60267-023-5.